publication venue for
- Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US. 2023
- Activating Transcription Factor 5 (ATF5) Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. 2023
- Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib. 2023
- Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas. 2023
- A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer.. 3. 2023
- The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.. 3. 2023
- Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities.. 3. 2023
- Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.. 3. 2023
- African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A.. 3. 2023
- Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation Approach.. 3. 2023
- Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia.. 2. 2022
- A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.. 2. 2022
- Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.. 2. 2022
- Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer.. 2. 2022
- A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.. 2. 2022